Monobactam and aminoglycoside combination therapy against metallo-β-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 3, 2010, Pages 231-233

  Araoka, Hideki ^a   Baba, Masaru ^a   Takagi, Shinsuke ^a   Matsuno, Naofumi ^a   Ishiwata, Kazuya ^a   Nakano, Nobuaki ^a   Tsuji, Masanori ^a   Yamamoto, Hisashi ^a   Seo, Sachiko ^a   Asano Mori, Yuki ^a   Uchida, Naoyuki ^a   Masuoka, Kazuhiro ^a   Wake, Atsushi ^a   Taniguchi, Shuichi ^a   Yoneyama, Akiko ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HABEKACIN; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; VANCOMYCIN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CASE REPORT; CELLULITIS; CORD BLOOD STEM CELL TRANSPLANTATION; EYE DISCHARGE; EYE SWELLING; FEMALE; FEVER; GENERAL CONDITION IMPROVEMENT; GRAFT VERSUS HOST REACTION; HUMAN; INTESTINE PERFORATION; LYMPHOMA; MALE; MULTIDRUG RESISTANCE; NEUTROPENIA; NEUTROPHIL COUNT; PERITONITIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEPSIS; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MONOBACTAMS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS; TREATMENT OUTCOME;

EID: 76649139483     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903443157     Document Type: Article

References (12)

1. Tateda K, Ishii Y, Matsumoto T, Yamaguchi K. 'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa. Scand J Infect Dis 2006;38:268-272
2. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239
3. Nishio H, Komatsu M, Shibata N, Shimakawa K, Sueyoshi N, Ura T, et al. Metallo-b-lactamase producing Gram-negative bacilli: laboratory based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J Clin Microbiol 2004;42:5256-5263
4. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, et al. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 2007;45:979-989
5. Docquier JD, Riccio ML, Mugnaioli C, Luzzaro F, Endimiani A, Toniolo A, et al. IMP-12, a new plasmid-encoded metallo-b-lactamase from a Pseudomonas putida clinical isolate. Antimicrob Agents Chemother 2003;47:1522-1528
6. Shaw KJ, Rather PN, Hare RS, Miller GH. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 1993;57:138-163
7. Shimizu K, Kumada T, Hsieh WC, Chung HY, Chong Y, Hare RS, et al. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother 1985;28:282-288
8. Yokoyama K, Doi Y, Yamane K, Kurokawa H, Shibata N, Shibayama K, et al. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 2003;362:1888-1893
9. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM effl ux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000;44:3322-3327
10. Tanaka N, Matsunaga K, Hirata A, Matsuhisa Y, Nishimura T. Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic. Antimicrob Agents Chemother 1983;24:797-802.
11. Watanabe T, Ohashi K, Matsui K, Kubota T. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillinresistant Staphylococcus aureus. J Antimicrob Chemother 1997;39:471-476
12. Kobayashi Y, Uchida H, Kawakami Y. Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa isolated from blood. J Antimicrob Chemother 1992;30:871-872